The future looks very bullish for this vaccine specialist. At the beginning of 2020, Novavax (NASDAQ:NVAX) had a valuation of $4 a share. Six months later, the company's stock sells for $47 a share. That's a dramatic shift in perception of value. What's the stock market seeing now that it didn't see in January? In a…
Novavax is well ahead in clinical testing than two of the White House's COVID-19 vaccine finalists. No company has developed a COVID-19 vaccine that's been proven to be safe and effective yet. But several appear to be getting a big boost for their efforts from Uncle Sam. The New York Times reported on Wednesday that…
Your 30s and 40s are what some would consider the best years of your life. You’re no longer “figuring it out,” but you aren’t “old” by society’s ageist standards either. It should be a sweet spot—right? But despite the illusion of stability and security, it’s also common for anxiety and self-doubt to worsen during your
5 min read WHEN THE JUSTICE Department released a trove of Epstein-related files on January 30 and then pulled down thousands of pages after redaction failures exposed victims’ identifying information and explicit material, I felt a familiar gut-drop. Once again, the people with the least power were being asked to pay twice—first for the abuse
You don't have permission to access "http://www.medpagetoday.com/obgyn/hrt/119940" on this server. Reference #18.5bf4d517.1771491743.1e0de1 https://errors.edgesuite.net/18.5bf4d517.1771491743.1e0de1